Suchergebnisse - (Subject:"COVID-19")

PubPharm (19)

1

Portable and Air Conditioner-Based Bio-Protection Devices to Prevent Airborne Infections in Acute and Long-Term Healthcare Facilities, Public Gathering Places, Public Transportation, and Similar Entities

enthalten in: Cureus | 2024

von Pisharodi, M.

2

A Transcriptomic Severity Classifier IMX-SEV-3b to Predict Mortality in Intensive Care Unit Patients with COVID-19 : A Prospective Observational Pilot Study

enthalten in: Journal of clinical medicine | 2023

von Daenen, K. | Tong-Minh, K. | Liesenfeld, O. | +6

3

Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes in a large generalisable population? A retrospective cohort study in the USA

enthalten in: BMJ open | 2023

von Griffin, D. | McNeil, C. | Okusa, J. | +3

4

Optimal Dosing and Timing of High-Dose Corticosteroid Therapy in Hospitalized Patients With COVID-19 : Study Protocol for a Retrospective Observational Multicenter Study (SELECT)

enthalten in: JMIR research protocols | 2023

von Daenen, K. | Huijben, J. | Boyd, A. | +118

5

Covid-19 Histamine theory : Why antihistamines should be incorporated as the basic component in Covid-19 management?

enthalten in: Health science reports | 2023

von Mashauri, H.

6

Covid‐19 Histamine theory: Why antihistamines should be incorporated as the basic component in Covid‐19 management?

in: Health Science Reports | 2023

von Harold L. Mashauri

7

A Transcriptomic Severity Classifier IMX-SEV-3b to Predict Mortality in Intensive Care Unit Patients with COVID-19: A Prospective Observational Pilot Study

in: Journal of Clinical Medicine | 2023

von Katrijn Daenen | Kirby Tong-Minh | Oliver Liesenfeld | +6

8

Cohort profile : Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination

enthalten in: BMJ open | 2022

von Collins, E. | Galipeau, Y. | Arnold, C. | +17

9

Temporal trends and differences of SARS-CoV-2-specific antibody responses in symptomatic and asymptomatic subjects : a longitudinal study from Umbria in Italy

enthalten in: BMJ open | 2022

von Abraha, I. | Eusebi, P. | Germani, A. | +13

10

Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19 : a systematic review and meta-analysis with GRADE assessment

enthalten in: Postgraduate medical journal | 2022

von Zein, A. | Sulistiyana, C. | Raffaello, W. | +2